Aktueller Stand der klinischen Anwendung

Dieses Positionspapier der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin (DGN) und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herzund Kreislaufforschung (DGK) ist eine Aktualisierung der gemeinsamen Stellungnahme aus dem Jahr 2008 (37), die den gegenwärtigen Erkenntnisstand zur nuklearkardiologischen Diagnostik wiedergibt und Ärztinnen und Ärzten und deren Patientinnen und Patienten die Entscheidungsfindung erleichtern soll. Das Positionspapier ersetzt nicht die ärztliche Evaluation im Einzelfall und die Anpassung der Diagnostik und Therapie an dessen spezifische Situation.

[1]  F. Tarazona-Santabalbina,et al.  Enfermedad por coronavirus 2019 (COVID-19) y edadismo: revisión narrativa de la literatura , 2020, Revista Española de Geriatría y Gerontología.

[2]  W. Burchert,et al.  Myocardial Perfusion SPECT 2018 in Germany: Results of the 8th Survey , 2019, Nuklearmedizin.

[3]  M. Schäfers,et al.  Harnessing the Maltodextrin Transport Mechanism for Targeted Bacterial Imaging: Structural Requirements for Improved in vivo Stability in Tracer Design , 2018, ChemMedChem.

[4]  S. Plein,et al.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology , 2018, Journal of Nuclear Cardiology.

[5]  U. Bavendiek,et al.  Targeting Cardiovascular Implant Infection: Multimodality and Molecular Imaging , 2017, Circulation. Cardiovascular imaging.

[6]  L. Cooper,et al.  Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring , 2017, Journal of Nuclear Cardiology.

[7]  J. Coselli,et al.  The American Association for Thoracic Surgery ( AATS ) consensus guidelines : Surgical treatment of infective endocarditis : Executive summary , 2017 .

[8]  R. Dörr.  ISCHEMIA-Studie – Rationale, Design und bisheriger Randomisierungsstatus , 2017, Der Nuklearmediziner.

[9]  L. Sharples,et al.  Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. , 2016, JAMA.

[10]  U. Bavendiek,et al.  Simultaneous dual-isotope solid-state detector SPECT for improved tracking of white blood cells in suspected endocarditis , 2016, European heart journal.

[11]  M. Schäfers,et al.  New molecular probes of vascular inflammation. , 2016, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

[12]  J. Zamorano,et al.  [2015 ESC Guidelines for the management of infective endocarditis]. , 2015, Kardiologia polska.

[13]  Dante Chiappino,et al.  Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population. , 2016, European heart journal cardiovascular Imaging.

[14]  Susanna Price,et al.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.

[15]  B. Hesse,et al.  EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  Jeroen J. Bax,et al.  Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure , 2015, Journal of Nuclear Cardiology.

[17]  B. Iung,et al.  Respective Performance of 18F-FDG PET and Radiolabeled Leukocyte Scintigraphy for the Diagnosis of Prosthetic Valve Endocarditis , 2014, The Journal of Nuclear Medicine.

[18]  F. Bengel,et al.  Cardiac molecular imaging. , 2014, Seminars in nuclear medicine.

[19]  D. Berman,et al.  Comparison of Image Quality, Myocardial Perfusion, and Left Ventricular Function Between Standard Imaging and Single-Injection Ultra-Low-Dose Imaging Using a High-Efficiency SPECT Camera: The MILLISIEVERT Study , 2014, The Journal of Nuclear Medicine.

[20]  Sung-Cheng Huang,et al.  Absolute Quantitation of Myocardial Blood Flow in Human Subjects With or Without Myocardial Ischemia Using Dynamic Flurpiridaz F 18 PET , 2014, The Journal of Nuclear Medicine.

[21]  Wen-Sheng Huang,et al.  Quantitation of myocardial blood flow and myocardial flow reserve with 99mTc-sestamibi dynamic SPECT/CT to enhance detection of coronary artery disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[22]  W. B. Meijboom,et al.  Added value of hybrid myocardial perfusion SPECT and CT coronary angiography in the diagnosis of coronary artery disease. , 2014, European heart journal cardiovascular Imaging.

[23]  Jeroen J. Bax,et al.  Risks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary artery disease. , 2014, European heart journal.

[24]  Juhani Knuuti,et al.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. , 2013, Journal of the American College of Cardiology.

[25]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[26]  G. Heller,et al.  The role of radionuclide imaging in heart failure , 2013, Journal of Nuclear Cardiology.

[27]  James A. White,et al.  Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial , 2013, Trials.

[28]  B. Iung,et al.  Role of radiolabelled leucocyte scintigraphy in patients with a suspicion of prosthetic valve endocarditis and inconclusive echocardiography. , 2013, European heart journal cardiovascular Imaging.

[29]  P. Erba,et al.  Added Value of 99mTc-HMPAO–Labeled Leukocyte SPECT/CT in the Characterization and Management of Patients with Infectious Endocarditis , 2012, The Journal of Nuclear Medicine.

[30]  H. Sipilä,et al.  Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.

[31]  M. Walsh,et al.  Etiology and pathophysiology of new-onset heart failure: Evaluation by myocardial perfusion imaging , 2009, Journal of Nuclear Cardiology.

[32]  R. Boellaard,et al.  Microvascular Function in Viable Myocardium After Chronic Infarction Does Not Influence Fractional Flow Reserve Measurements , 2007, Journal of Nuclear Medicine.

[33]  Jeroen J. Bax,et al.  Hibernating myocardium: diagnosis and patient outcomes. , 2007, Current problems in cardiology.

[34]  D. Berman,et al.  Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.

[35]  E. Natour,et al.  Diagnostic value of imaging in infective endocarditis: a systematic review. , 2017, The Lancet. Infectious diseases.

[36]  oNe mediciNe,et al.  Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM) , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[37]  B. Gersh,et al.  ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .

[38]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[39]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[40]  Nationale VersorgungsLeitlinie.  Bundesärztekammer Kassenärztliche Bundesvereinigung Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften , 2011 .

[41]  O. Schober,et al.  Position paper nuclear cardiology: Update 2008 , 2009, Nuklearmedizin.